Related Experiment Video
Updated: Apr 19, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.1K
Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping
Yuexin Liu1, Russell R Broaddus, Wei Zhang
1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Expert Review of Anticancer Therapy
|December 16, 2014
Abstract:
Clinical heterogeneity represents a great challenge for cancer therapeutics. Molecular classification of patients into different subtypes based on genetic or epigenetic characteristics has the potential to revolutionize the clinical care and mechanistic understanding of a wide spectrum of cancers, including endometrial carcinoma, the most common gynecological cancer affecting women.
